Ronald Christopher Roberts

7PUBLICATIONS
34CO-AUTHORS
Molecular targetsMedical physiology not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 22, 2026
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.

|May 01, 2023
Disseminated Peritoneal Tuberculosis Initially Misdiagnosed as Nephrogenic Ascites.

Lauren Crossman, Christopher Ronald Funk, Sheetal Kandiah

|Jun 10, 2022
KIT Mutations Correlate with Higher Galectin Levels and Brain Metastasis in Breast and Non-Small Cell Lung Cancer.

Avery T Funkhouser, Alexander M Strigenz, Bailey B Blair

|Jan 27, 2022
PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.

Christopher Ronald Funk, Shuhua Wang, Kevin Z Chen

|Oct 13, 2021
Increased Circulating Levels of Galectin Proteins in Patients with Breast, Colon, and Lung Cancer.

Bailey B Blair, Avery T Funkhouser, Jane L Goodwin

|Dec 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case Report.

Christopher Ronald Funk, Christopher T Petersen, Neera Jagirdar

Pageof 2

Frequent Collaborators

2 joint publications

Julie C Martin

2 joint publications

Anna V Blenda

2 joint publications

Sruthi Ravindranathan

2 joint publications

Edmund K Waller